Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac allograft vasculopathy--problem and model.

W von Scheidt1

  • 1Medizinische Klinik und Poliklinik I Klinikum Grosshadern Ludwig-Maximilians-Universität München 81366 München, Germany. wolfgang.scheidt@med1.med.uni-muenchen.de

Zeitschrift Fur Kardiologie
|January 11, 2001
PubMed
Summary

Cardiac allograft vasculopathy (CAV), a major cause of death after heart transplants, involves accelerated atherosclerosis due to immune injury and inflammation. Developing early risk prediction is crucial for better prevention and treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 risk perceptions, worries and preventive behaviors in patients with previous myocardial infarction: results from the myocardial infarction registry Augsburg.

Psychology, health & medicine·2022
Same author

[Syncope].

Der Internist·2020
Same author

The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study.

Respiratory research·2018
Same author

The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study.

BMC pulmonary medicine·2017
Same author

Obstructive sleep apnea might trigger acute pulmonary embolism: results from a cohort study.

Clinical research in cardiology : official journal of the German Cardiac Society·2016
Same author

Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry.

Clinical research in cardiology : official journal of the German Cardiac Society·2014

Area of Science:

  • Cardiovascular Medicine
  • Transplantation Immunology
  • Vascular Biology

Background:

  • Cardiac allograft vasculopathy (CAV) is accelerated atherosclerosis post-transplantation.
  • It's the primary cause of death beyond one year, driven by immune injury and inflammation.
  • Current understanding of CAV's complex mechanisms and heterogeneous presentation is limited.

Purpose of the Study:

  • To highlight the need for an early risk prediction algorithm for CAV.
  • To emphasize CAV as a unique human model for studying atherosclerosis.
  • To explore insights gained from experimental animal models of CAV.

Main Methods:

  • Review of existing literature on CAV pathogenesis and clinical manifestations.
  • Analysis of experimental animal models to dissect injury cascade mechanisms.

Related Experiment Videos

  • Correlation of vascular function and morphology with mediator expression in human CAV.

    • Main Results:

    • CAV involves complex immunological and non-immunological risk factors.
    • Experimental models provide specific insights into key CAV mechanisms.
    • Human CAV offers a unique platform to study atherosclerosis, linking vascular changes to mediator activity.

    Conclusions:

    • Early risk prediction for CAV is essential for improved preventive and therapeutic strategies.
    • CAV serves as a valuable human model for atherosclerosis research.
    • Further investigation into CAV mechanisms can offer broader insights into vascular disease.